Treatment of refractory human tumors with epidermal growth factor receptor antagonists

Treatment of refractory human tumors with epidermal growth factor receptor antagonists

  • CN 1,200,734 C
  • Filed: 05/01/2000
  • Issued: 05/11/2005
  • Est. Priority Date: 05/14/1999
  • Status: Active Grant
First Claim
Patent Images

1. the epidermal growth factor of effective dose (EGFR) antagonist is applied to the people with the purposes in the medicine that suppresses the intractable tumor growth in preparation, this intractable tumor can not be treated or described treatment is had resistance in described people with antitumor agent, and wherein antagonist is specific antibody or its function equivalent of EGFR.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×